Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F6X7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,194
Award facts
- Contract value 100% obligated
- $15,193.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,193.94 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside contract was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle that extends through December 2026 and enables the company to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Health Agency and related government entities. The company has demonstrated sustained capability to fulfill federal pharmaceutical supply needs through competitive award processes, with its extensive contract portfolio encompassing specialty medications, brand-name and generic drugs, and specialized medical devices across multiple therapeutic domains. This delivery order for Enbrel, a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, exemplifies the company's role in supplying essential pharmaceutical products to support military medical readiness.
Quick answers
Who was awarded contract SPE2DR26F6X7N?
SPE2DR26F6X7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6X7N worth?
The government has obligated $15,194 on SPE2DR26F6X7N.
Is contract SPE2DR26F6X7N an order under another contract?
Yes. SPE2DR26F6X7N is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X7N competed?
The extent of competition for SPE2DR26F6X7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award